Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Gilbert

Showing results (141-150 of 173) with videos related to

Pageof 18
Sort By:
Stem Cells (Dayton, Ohio)|August 8, 2013
Early outgrowth cells release soluble endocrine antifibrotic factors that reduce progressive organ fibrosisDarren A Yuen, Kim A Connelly, Yanling Zhang, et al.
Physiological Reports|June 29, 2021
Impact of sodium glucose linked cotransporter-2 inhibition on renal microvascular oxygen tension in a rodent model of diabetes mellitusGregory M T Hare, Yanling Zhang, Kyle Chin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 12, 2020
The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trialErika Opingari, Subodh Verma, Kim A Connelly, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2007
Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditionsAndrew Advani, Darren J Kelly, Suzanne L Advani, et al.
International Journal of Cardiology|December 11, 2012
A new anti-fibrotic drug attenuates cardiac remodeling and systolic dysfunction following experimental myocardial infarctionYuan Zhang, Maros Elsik, Amanda J Edgley, et al.
Cardiovascular Diabetology|October 5, 2021
Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetesBradley Sarak, Subodh Verma, C David Mazer, et al.
Journal of Diabetes Investigation|April 22, 2025
Induction of proximal tubular proliferation and lengthening in response to sodium glucose linked cotransporter-2 inhibition in experimental ratsEllen Wu, Sarah Macklin, Yanling Zhang, et al.
Journal of the American Society of Nephrology : JASN|February 13, 2016
Recombinant N-Terminal Slit2 Inhibits TGF-β-Induced Fibroblast Activation and Renal FibrosisDarren A Yuen, Yi-Wei Huang, Guang-Ying Liu, et al.
Plos One|March 9, 2010
Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanismDarren A Yuen, Kim A Connelly, Andrew Advani, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|November 11, 2020
Renal microvascular oxygen tension during hyperoxia and acute hemodilution assessed by phosphorescence quenching and excitation with blue and red lightKyle Chin, Melina P Cazorla-Bak, Elaine Liu, et al.
Pageof 18

Showing results (141-150 of 173) with videos related to

Sort By:
Pageof 18
Stem Cells (Dayton, Ohio)|August 8, 2013
Early outgrowth cells release soluble endocrine antifibrotic factors that reduce progressive organ fibrosisDarren A Yuen, Kim A Connelly, Yanling Zhang, et al.
Physiological Reports|June 29, 2021
Impact of sodium glucose linked cotransporter-2 inhibition on renal microvascular oxygen tension in a rodent model of diabetes mellitusGregory M T Hare, Yanling Zhang, Kyle Chin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 12, 2020
The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trialErika Opingari, Subodh Verma, Kim A Connelly, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2007
Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditionsAndrew Advani, Darren J Kelly, Suzanne L Advani, et al.
International Journal of Cardiology|December 11, 2012
A new anti-fibrotic drug attenuates cardiac remodeling and systolic dysfunction following experimental myocardial infarctionYuan Zhang, Maros Elsik, Amanda J Edgley, et al.
Cardiovascular Diabetology|October 5, 2021
Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetesBradley Sarak, Subodh Verma, C David Mazer, et al.
Journal of Diabetes Investigation|April 22, 2025
Induction of proximal tubular proliferation and lengthening in response to sodium glucose linked cotransporter-2 inhibition in experimental ratsEllen Wu, Sarah Macklin, Yanling Zhang, et al.
Journal of the American Society of Nephrology : JASN|February 13, 2016
Recombinant N-Terminal Slit2 Inhibits TGF-β-Induced Fibroblast Activation and Renal FibrosisDarren A Yuen, Yi-Wei Huang, Guang-Ying Liu, et al.
Plos One|March 9, 2010
Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanismDarren A Yuen, Kim A Connelly, Andrew Advani, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|November 11, 2020
Renal microvascular oxygen tension during hyperoxia and acute hemodilution assessed by phosphorescence quenching and excitation with blue and red lightKyle Chin, Melina P Cazorla-Bak, Elaine Liu, et al.
Pageof 18